Maravai LifeSciences Holdings, Inc. (MRVI) vs Nurix Therapeutics, Inc. (NRIX)
A side-by-side comparison of Maravai LifeSciences Holdings, Inc. and Nurix Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MRVI
Maravai LifeSciences Holdings, Inc.
$7.85HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NRIX
Nurix Therapeutics, Inc.
$22.60HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — MRVI vs NRIX
growth of $100 · dividends reinvested · last 6yMRVI -71.5% (-18.9%/yr)NRIX -39.2% (-8.0%/yr)NRIX compounded faster over this window
MRVI NRIX
MRVI vs NRIX: by the numbers
- •NRIX is the larger company ($2.35B vs $2.17B market cap).
- •Both run net losses; MRVI's is the smaller (-37.07% vs -928.44% net margin).
- •NRIX grew revenue faster over the past five years (9.96% vs -17.68% CAGR).
Metrics side by side
Valuation
| Metric | MRVI | NRIX |
|---|---|---|
| P/S ratio | 10.39 | 63.79 |
| P/B ratio | 10.60 | 5.83 |
| EV / EBITDA | 15.02 | N/A |
Profitability
| Metric | MRVI | NRIX |
|---|---|---|
| Gross margin | 17.98% | 77.55% |
| Operating margin | -3.63% | -340.16% |
| Net margin | -37.07% | -928.44% |
| ROE | -37.82% | -84.78% |
| ROIC | 16.96% | -77.92% |
Growth (annualized)
| Metric | MRVI | NRIX |
|---|---|---|
| Revenue CAGR (5Y) | -17.68% | 9.96% |
| Total return CAGR (5Y) | -27.63% | -5.51% |
Frequently asked
- Which has grown faster, MRVI or NRIX?
- Over the past five years, NRIX grew revenue faster — MRVI at a -17.68% CAGR versus NRIX at 9.96%.
- How have MRVI and NRIX total returns compared?
- Over the past 5 years, MRVI delivered -27.63% and NRIX delivered -5.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.